
Interview with CEO Angelo Stracquatanio Part 3
From a $2.5M round to over $200M raised today, hear how Apprentice was able to balance rapid innovation with regulatory compliance, and why their next chapter - the AI era - promises to revolutionize how therapeutics are manufactured.